Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-13 20:26 | 2026-05-12 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | SALE | $36.74 | 18,500 | $679,747 | 216,744 | -7.9% |
| 2026-04-15 20:57 | 2026-04-14 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | SALE | $44.05 | 22,951 | $1,011,051 | 235,244 | -8.9% |
| 2026-02-26 03:58 | 2026-02-23 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | SALE | $41.98 | 16,925 | $710,578 | 257,163 | -6.2% |
| 2025-02-28 00:05 | 2025-02-21 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | SALE | $27.78 | 19,688 | $546,913 | 204,665 | -8.8% |
| 2025-01-11 00:06 | 2025-01-08 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $41.74 | 17,500 | $730,536 | 143,603 | -10.9% |
| 2024-12-21 00:06 | 2024-12-18 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $43.07 | 17,500 | $753,680 | 85,942 | -16.9% |
| 2024-12-14 00:07 | 2024-12-11 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $46.94 | 17,500 | $821,524 | 85,942 | -16.9% |
| 2024-11-28 00:05 | 2024-11-25 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $47.98 | 19,375 | $929,560 | 85,942 | -18.4% |
| 2024-11-16 00:05 | 2024-11-13 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $49.50 | 30,625 | $1,516,039 | 85,942 | -26.3% |
| 2024-10-25 23:04 | 2024-10-23 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $40.39 | 19,375 | $782,611 | 307,972 | -5.9% |
| 2024-10-11 23:05 | 2024-10-09 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $38.24 | 15,625 | $597,569 | 307,972 | -4.8% |
| 2024-09-27 23:05 | 2024-09-25 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $46.05 | 23,125 | $1,064,809 | 307,972 | -7.0% |
| 2024-09-13 23:36 | 2024-09-11 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $37.50 | 15,625 | $585,934 | 307,972 | -4.8% |
| 2024-08-30 23:04 | 2024-08-28 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $36.85 | 30,320 | $1,117,140 | 307,972 | -9.0% |
| 2024-08-24 00:40 | 2024-08-21 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | SALE | $39.76 | 14,471 | $575,425 | 322,667 | -4.3% |
| 2024-08-16 23:31 | 2024-08-14 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $37.56 | 15,625 | $586,927 | 337,138 | -4.4% |
| 2023-08-24 00:56 | 2023-08-21 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $16.66 | 5,210 | $86,779 | 243,361 | -2.1% |
| 2022-10-05 23:05 | 2022-10-03 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $20.90 | 32,000 | $668,774 | 181,150 | -15.0% |
| 2022-09-14 23:12 | 2022-09-13 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $21.16 | 22,363 | $473,237 | 181,150 | -11.0% |
| 2022-09-13 23:04 | 2022-09-09 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $20.43 | 29,022 | $592,812 | 181,150 | -13.8% |
| 2022-09-09 23:23 | 2022-09-07 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $20.37 | 21,891 | $445,878 | 181,150 | -10.8% |
| 2022-09-06 23:29 | 2022-09-01 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $21.09 | 34,196 | $721,235 | 181,150 | -15.9% |
| 2022-08-15 23:11 | 2022-08-12 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; President and CEO | Pharmaceutical Preparations | OPT+S | $20.16 | 20,528 | $413,799 | 137,400 | -13.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.